Using genetic markers to understand pancreatic and liver cancer origins
Genomic lineage traces as biomarkers for human pancreatic and liver cancer
This study is looking at how the genes of pancreatic and liver cancer cells can help us understand where the cancer started and how it behaves, so we can better match treatments to patients and improve their care.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11030318 on NIH RePORTER |
What this research studies
This research investigates how the origin of cancer cells in pancreatic and liver cancers can be traced through specific genetic markers. By analyzing these markers, researchers aim to understand how different subtypes of these cancers develop and how they relate to patient outcomes. The study utilizes advanced techniques to identify these lineage traces, which could help in classifying tumors and tailoring treatments for patients. The ultimate goal is to improve patient stratification based on the genetic characteristics of their tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma or hepatocellular carcinoma.
Not a fit: Patients with other types of cancer or those without a confirmed diagnosis of pancreatic or liver cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment strategies for patients with pancreatic and liver cancers.
How similar studies have performed: Previous studies have shown promise in using genetic markers to understand cancer origins, suggesting that this approach could yield valuable insights.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Murtaugh, Lewis C — University of Utah
- Study coordinator: Murtaugh, Lewis C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.